Skip to main content
Premium Trial:

Request an Annual Quote

Johns Hopkins to Use Axela's dotLab Protein-Detection Technology in Cardiac Trial

NEW YORK (GenomeWeb News) – Johns Hopkins University researchers will use Axela’s dotLab protein-detection technology in a clinical trial to evaluate the prognostic value of certain complexes for acute myocardial infarction, Axela said today.
Under the agreement, scientists at the Johns Hopkins NHLBI Proteomics Center will study Troponin complexes as well as modifications to cardiac Troponin I in patients with AMI. Troponin is a complex of three proteins that is integral to the contraction of cardiac muscle and is released into the blood during cardiac muscle necrosis and cell death.
The assay Johns Hopkins will test can detect Troponin circulating in the blood of AMI patients.
Axela's CEO, Rocky Ganske, said the research could result in “a valuable prognostic tool for the treatment of heart attacks that impact so many lives.”
Axela said Johns Hopkins has granted the company the option to negotiate exclusive rights to intellectual property the trial generates.
Axela's dotLab is an automated sampling system and fluidic controller that presents data in real time using specialized software. Ganske said that the system's ability to measure protein complexes directly in serum in a single test has the potential "to significantly impact heart attack treatment protocols, but could also be applied do many other diseases."

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.